drugset / Trial / NCT05550129

Study to Evaluate the Drug-drug Interactions Between Metformin and AMG 510 in Healthy Participants

NCT05550129

Phase 1 Completed 13 enrolled Amgen
NaSingle-groupOpen-labelBasic science

Summary

The primary objectives of this study are to evaluate the effect of AMG 510 on the pharmacokinetics (PK) of metformin in healthy participants and to evaluate the effect of metformin on the PK of AMG 510 in healthy participants.

Timeline

Start
2019-11-13
Primary completion
2019-11-25
Completion
2019-11-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule Oral
Subject Sotorasib Small molecule Oral

Indications

No indication recorded.